Trials / Terminated
TerminatedNCT05105477
Hypotension Prediction Index (HPI) SMART-BP Trial
Hypotension Prediction Index (HPI) Software Guided Hemodynamic Management for Noncardiac Surgery Patients - Blood Pressure Trial (National PI: Kamal Maheshwari, MD, MPH)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 407 (actual)
- Sponsor
- Edwards Lifesciences · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A multicenter, randomized comparison of intraoperative hemodynamic management with or without a protocolized strategy utilizing Hypotension Prediction Index (HPI) software guidance during moderate-to-high-risk noncardiac surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AcumenTM HPI Software Feature | The AcumenTM HPI Feature Software provides the clinician with physiological insight into a patient's likelihood of trending toward a hypotensive event. The AcumenTM HPI Feature Software suite is enabled by the minimally invasive Acumen IQ sensor. |
| OTHER | Non-protocolized Standard of Care | Non-protocolized standard of care to treat subjects |
Timeline
- Start date
- 2021-11-17
- Primary completion
- 2022-12-15
- Completion
- 2022-12-15
- First posted
- 2021-11-03
- Last updated
- 2024-03-25
- Results posted
- 2024-03-25
Locations
11 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05105477. Inclusion in this directory is not an endorsement.